UBS Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $191M | Buy |
|
|||||
|
2025
Q2 | $154M | Buy |
|
|||||
|
2025
Q1 | $182M | Sell |
|
|||||
|
2024
Q4 | $273M | Buy |
|
|||||
|
2024
Q3 | $286M | Buy |
|
|||||
|
2024
Q2 | $267M | Sell |
|
|||||
|
2024
Q1 | $248M | Buy |
|
|||||
|
2023
Q4 | $119M | Buy |
|
|||||
|
2023
Q3 | $85.9M | Sell |
|
|||||
|
2023
Q2 | $115M | Buy |
|
|||||
|
2023
Q1 | $83.7M | Sell |
|
|||||
|
2022
Q4 | $100M | Buy |
|
|||||
|
2022
Q3 | $35.2M | Sell |
|
|||||
|
2022
Q2 | $73.5M | Buy |
|
|||||
|
2022
Q1 | $73.6M | Sell |
|
|||||
|
2021
Q4 | $119M | Sell |
|
|||||
|
2021
Q3 | $125M | Buy |
|
|||||
|
2021
Q2 | $88.1M | Sell |
|
|||||
|
2021
Q1 | $75M | Buy |
|
|||||
|
2020
Q4 | $67.4M | Buy |
|
|||||
|
2020
Q3 | $45.7M | Sell |
|
|||||
|
2020
Q2 | $79.1M | Buy |
|
|||||
|
2020
Q1 | $46.9M | Sell |
|
|||||
|
2019
Q4 | $45.2M | Sell |
|
|||||
|
2019
Q3 | $39.1M | Buy |
|
|||||
|
2019
Q2 | $33.6M | Sell |
|
|||||
|
2019
Q1 | $71M | Buy |
|
|||||
|
2018
Q4 | $39.3M | Sell |
|
|||||
|
2018
Q3 | $49.1M | Buy |
|
|||||
|
2018
Q2 | $34M | Buy |
|
|||||
|
2018
Q1 | $29.7M | Sell |
|
|||||
|
2017
Q4 | $51.4M | Buy |
|
|||||
|
2017
Q3 | $41.5M | Buy |
|
|||||
|
2017
Q2 | $30.9M | Buy |
|
|||||
|
2017
Q1 | $21.5M | Buy |
|
|||||
|
2016
Q4 | $15M | Buy |
|
|||||
|
2016
Q3 | $15.2M | Buy |
|
|||||
|
2016
Q2 | $11.1M | Buy |
|
|||||
|
2016
Q1 | $10.7M | Sell |
|
|||||
|
2015
Q4 | $38.7M | Buy |
|
|||||
|
2015
Q3 | $25.2M | Sell |
|
|||||
|
2015
Q2 | $41.6M | Sell |
|
|||||
|
2015
Q1 | $39.7M | Sell |
|
|||||
|
2014
Q4 | $40.4M | Buy |
|